Tocotrienol
Sponsors
Hadassah Medical Organization, Malaysia Palm Oil Board, Universiti Sains Malaysia, Seberang Jaya Clinical Research Centre, Vejle Hospital
Conditions
AbsorptionBreast CancerCognitive ImpairmentColorectal CancerColorectal Cancer MetastaticCystic FibrosisDiabetic NeuropathyIschemic Stroke
Phase 2
Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer
CompletedNCT02705300
Start: 2016-05-06End: 2024-03-27Updated: 2024-08-29
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
CompletedNCT04175470
Start: 2019-10-29End: 2024-12-31Updated: 2025-01-03
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer
Active, not recruitingNCT04245865
Start: 2020-06-26End: 2026-12-01Updated: 2026-04-03
Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial.
CompletedNCT04496492
Start: 2016-02-09End: 2017-07-06Updated: 2020-08-03
Phase 3
Unknown Phase
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)
CompletedNCT00889434
Start: 2011-11-01End: 2015-04-16Updated: 2017-11-30
Study of Tocotrienol Absorption and Distribution Under Different Fat Status
CompletedNCT01185769
Start: 2009-09-30End: 2009-09-30Updated: 2010-08-20